参松养心胶囊合并黛力新治疗心肌梗死后抑郁症的疗效观察  

The Therapeutic Effect of Shensongyangxin Capsule Combined with Deanxit in Treatment of Depression Following Myocardial Infarction Curative Effect Observation

作　　者：闵晓梅[1] 

机构地区：[1]四川省内江市第六人民医院心内科,四川内江641000

出　　处：《中国医药指南》2013年第10期406-407,共2页Guide of China Medicine

摘　　要：目的观察参松养心胶囊合并黛力新治疗心肌梗死后抑郁症的临床疗效。方法随机抽取2008年1月至2012年6月间于我院住院治疗的86例心肌梗死后抑郁症患者作为研究对象。将86例患者随机分成治疗组、对照组,各43例。对照组:口服黛力新,1片/次,1次/天,疗程8周;治疗组:口服黛力新,1片/1次,1次/天,参松养心胶囊,4粒/次,3次/天,疗程8周。采用汉密尔顿抑郁量表(HAMD)评分对治疗效果进行评估。结果治疗前、治疗8周末HAMD评分分别为:对照组21.3±2.2、16.5±1.8;治疗组21.8±2.3、11.2±1.4。两组经系统治疗均获得良好治疗效果,综合对比、分析表明治疗组治疗效果要明显优于对照组(P<0.05)。结论参松养心胶囊明显增强黛力新抗抑郁效果,其合并黛力新在治疗心肌梗死后抑郁症上临床效果满意,不良反应少。Objective Effect of Shensongyangxin capsule combined with Deanxit in treatment of depression following myocardial infarction clinical curative effect. Methods 86 patients with depression after myocardial infarction were randomly divided into two groups, every group were 43 eases, oral onl,1 times / day, Shensong Yangxin Capsule 4 pills,3 times / day,8 weeks,43 eases in the control group, oral onl,1 times per day, for 8 weeks, with Hamilton depressive scale （ HAMD ） score. Results In the eighth weekend of HAMD score, the treatment group was 11.2±1.4, 16.5±1.8of control group. The treatment group after treatment than before treatment has improved significantly （P〈0.05）. Conclusion Shensongyangxin capsule significantly enhances antidepressant effect of deanxit.

关 键 词：黛力新 参松养心胶囊 心肌梗死后抑郁症 

分 类 号：R542.22[医药卫生—心血管疾病]